YD Bio (YDES) Stock Analysis: AI Score & Alternative Data
YDES alt-data: web traffic climbing, headcount lagging
Is YD Bio a buy right now? The alternative data says hold. This YDES stock analysis is built on the 25+ alternative data signals AltIndex tracks on YD Bio every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 56/100: a Hold. The stock trades at $5.79 with a $416M market cap.
The bullish side of the 90-day ledger: web traffic up 637.3% to 929 monthly visits. The drag: headcount (according to LinkedIn) down 25.0% to 3 employees. That tension is what keeps the score mid-range.
YDES’s broader alt-data profile also covers X followers (31), and sentiment (100/100). Every signal links to its own page with full history, the YDES technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on YDES is just below.
YD Bio AI Stock Analysis
YD Bio, a company operating in the biotechnology sector, focuses primarily on research and development of advanced biological products. The firm is involved in cutting-edge pharmaceutical innovations and biotechnological solutions. The market landscape for YD Bio is highly competitive, with sizeable investment in R&D to maintain its edge.
Analysis generated October 1, 2026.
Recent YD Bio Stock Alerts
|
YD Bio | October 7 Price is down by -8.1% in the last 24h. |
|
YD Bio | October 6 Price is down by -8% in the last 24h. |
|
YD Bio | October 5 Price is down by -8.4% in the last 24h. |
|
YD Bio | October 2 Price is down by -9.6% in the last 24h. |
YD Bio Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 929 | 637.3% | |
| Job Posts | 0 | N/A | |
| LinkedIn Employees | 3 | 25.0% | |
| Sentiment | 100 | 0% | |
| Reddit Mentions | 0 | N/A | |
| X Mentions | 3 | 85.0% | |
| Stocktwits Mentions | 2 | 93.3% | |
| News Mentions | 0 | N/A | |
| Stocktwits Subscribers | 222 | 2.3% | |
| X Followers | 31 | 3.3% |
About YD Bio (YDES)
Breeze Holdings Acquisition Corp. The company is headquartered in Taipei, Taiwan.
| Price | $5.79 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $416M |
| Year Range | $2 – $20 |
| Dividend Yield | 0% |
| PE Ratio | — |
| Analyst Rating | 38% buy |
| Industry | Biotechnology |
Latest YD Bio News
View more →
YD Bio Expands U.S. Laboratory Footprint to 46 States, Strengthening DNA-Methylation Early Cancer Detection OperationsJuly 2 - GlobeNewswire |
See YD Bio’s complete price and AI Score history
Sign up to unlock 1-year and all-time charts for YDES, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREEYD Bio Earnings & Financial Performance
View all earnings →YD Bio Insider Trading Activity
View all →| Shen Ethan PhD filed to sell 11,258,331 shares at $0.0. Sep 14 '26 |
| Shen Ethan PhD filed to sell 11,245,631 shares at $0.0. Sep 9 '26 |
| Shen Ethan PhD filed to sell 11,242,531 shares at $0.0. Sep 4 '26 |
YD Bio Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| No congress trades on file. | |||
Stocks Similar to YD Bio
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
 |
CybinCYBN |
$8.28 1.2% | $413M | 41 |
 |
PureTech HealthPRTC |
$17.42 2.0% | $420M | 44 |
 |
Editas MedicineEDIT |
$2.84 3.3% | $422M | 57 |
 |
DiaMedica TherapeuticsDMAC |
$8.01 0.3% | $431M | 52 |
 |
Atea PharmaceuticalsAVIR |
$5.16 2.9% | $402M | 48 |
Explore YD Bio Data
Frequently Asked Questions: YD Bio (YDES)
YD Bio has an AltIndex AI Score of 56/100 (Hold). The score reflects mixed alternative data signals. All investments carry risk.
56/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of YD Bio (YDES) stock is $5.79 with a market cap of $416M.
As of today, YD Bio’s PE (Price to Earnings) ratio is —.
View the latest YD Bio insider transactions to see recent buying and selling activity by company executives and directors.
Check the YD Bio congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The YDES stock price chart above shows YD Bio’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full YD Bio technical analysis for RSI, moving averages, and more.
See the stocks similar to YD Bio section on this page for companies in the same industry ranked by market cap and AI Score.
